Virax Biolabs is an innovative Biotechnology company focused on the prevention, detection and diagnosis of viral diseases. The company is a revenue generating group operating since 2013 whose primary business is the proprietary development and global distribution of in vitro diagnostic (IVD) test kits.
Virax Immune is our flagship product focused on the global provision of T-Cell tests, which accurately and effectively predict an individual’s immune response to significant viral threats. This life impacting product offering is scheduled to be available for distribution Q3 2022. Virax also offers a range of In Vitro Diagnostic devices, AI sanitizers and other innovative technologies through its’ ViraxClear and ViraxCare platforms.
Company’s Keywords:
ioth, medical device development, procurement, tcells, immunology, medical device distribution, innovation, logistics, ppe, distribution
<10
<
<2016